COVID-19 Upends Business-As-Usual

In this ISSUE

Consider Data Before It’s a Problem

Social Media’s Influence in Messaging Mix

Blood Feud Divides Europe Over Plasma Shortfalls

Executive Profile

Habib Bennaceur: Following the Science

AstraZeneca’s Habib Bennaceur talks about his key career transitions and his current role in positioning AZ’s Farxiga as a drug with the potential to impact the lives of both patients with and without type 2 diabetes.
... /Read more/

Coronavirus

COVID-19 Upends Business-as-usual Research and Regulatory Practices

Now officially a worldwide pandemic, the biomedical research community is rushing to develop treatments and preventives to halt the spread and severity of the COVID-19 virus.
... /Read more/

Artificial Intelligence

How UCB Transformed into a More Agile, Data-Driven Organization

Anita Moser, Michael Davis, Dharmendra Sahay outline UCB's measured approach to scaling its AI capabilities.
... /Read more/

Calendar

/ DIA 2020 Global Annual Meeting — 6/14-6/18 /

/ BePharma 2020 — 6/15-6/17 /

/ Patient Support Services Congress— 6/16-6/18 /

News

"Time to Flip the Digital Switch:" COVID-19 and Pharma Sales

ZS offers advice to ensure reps can stay engaged with their customers during these times of changing needs and constraints.
... /Read more/

The Pharm Exec Podcast: Episode 52

Cannabinoids

Yuval Cohen, CEO of Corbus Pharmaceuticals, talks about cannabinoids, the differences between natural and synthetic products, and how biotechs and pharma are using them to treat disease today.
... /Read more/

update my profile / advertise with us / print & digital subscribe / visit pharmexec.com